The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice
- 1 June 2000
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 61 (3) , 217-228
Abstract
HER-2/neuis overexpressed on a variety of human adenocarcinomas and overexpression has been associated with a poor prognosis. For this reason, HER-2 has become an attractive target for...Keywords
This publication has 31 references indexed in Scilit:
- ERBB2 oncogene in human breast cancer and its clinical significanceEuropean Journal of Cancer, 1998
- HER-2/neu Protein: A Target for Antigen-Specific Immunotherapy of Human Cancer1997
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.Journal of Clinical Oncology, 1996
- Preclinical testing of an anti-erbB-2 recombinant toxinBreast Cancer Research and Treatment, 1996
- Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibodyBritish Journal of Cancer, 1995
- Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growthBritish Journal of Cancer, 1993
- Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.Proceedings of the National Academy of Sciences, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985